购物车
- 全部删除
- 您的购物车当前为空
Montelukast (MK0476) dicyclohexylamine 是一种有效、选择性且具口服活性的半胱氨酸白三烯受体1 (CysLT1) 拮抗剂,用于哮喘和肝损伤预防研究。它在肠缺血-再灌注损伤中展现抗氧化作用,减轻心脏损伤,并降低嗜酸性粒细胞对哮喘气道的浸润。此外,亦被用于COVID-19的研究。
Montelukast (MK0476) dicyclohexylamine 是一种有效、选择性且具口服活性的半胱氨酸白三烯受体1 (CysLT1) 拮抗剂,用于哮喘和肝损伤预防研究。它在肠缺血-再灌注损伤中展现抗氧化作用,减轻心脏损伤,并降低嗜酸性粒细胞对哮喘气道的浸润。此外,亦被用于COVID-19的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 11,700 | 1-2周 | |
50 mg | ¥ 15,300 | 1-2周 | |
100 mg | ¥ 19,500 | 1-2周 |
产品描述 | Montelukast dicyclohexylamine (MK0476), a potent, selective, and orally active antagonist of the cysteinyl leukotriene receptor 1 (CysLT1), is utilized in the research of asthma, liver injury, and COVID-19. It exhibits antioxidant properties in the context of intestinal ischemia-reperfusion injury and can mitigate cardiac damage. Additionally, it reduces eosinophil infiltration in the airways of asthmatic patients. |
别名 | MK0476 dicyclohexylamine |
分子量 | 767.5 |
分子式 | C47H59ClN2O3S |
CAS No. | 577953-88-9 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容